ROCALTROL CAPSULE
Država: Kanada
Jezik: angleščina
Source: Health Canada
Lastnosti izdelka
(SPC)
26-01-2021
Nekateri dokumenti za ta izdelek trenutno niso na voljo, pošljete lahko zahtevo v našo stranko in obvestili vas bomo takoj, ko jih bomo lahko pridobili.
Pošlji zahtevo.
Pošlji zahtevo.
Aktivna sestavina:
CALCITRIOL
Dostopno od:
SEARCHLIGHT PHARMA INC
Koda artikla:
A11CC04
INN (mednarodno ime):
CALCITRIOL
Odmerek:
0.5MCG
Farmacevtska oblika:
CAPSULE
Sestava:
CALCITRIOL 0.5MCG
Pot uporabe:
ORAL
Enote v paketu:
100
Tip zastaranja:
Prescription
Terapevtsko območje:
VITAMIN D
Povzetek izdelek:
Active ingredient group (AIG) number: 0113628005; AHFS:
Status dovoljenje:
APPROVED
Datum dovoljenje:
2021-01-27
Lastnosti izdelka
_ _
_ _
_Page 1 of 25_
PRODUCT MONOGRAPH
PR
ROCALTROL
®
Calcitriol Capsules
Capsules 0.25 mcg and 0.5 mcg
Vitamin D3 Metabolite
Searchlight Pharma Inc.
1600 Notre-Dame Street W. Suite 312
Montreal, Quebec
H3J 1M1
Date of Revision:
January 26, 2021
Submission Control No.: 247457
_ _
_ _
_Page 2 of 25_
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................3
WARNINGS AND PRECAUTIONS
..................................................................................4
ADVERSE REACTIONS
....................................................................................................5
DRUG INTERACTIONS
....................................................................................................7
DOSAGE AND ADMINISTRATION
................................................................................8
OVERDOSAGE
................................................................................................................10
ACTION AND CLINICAL PHARMACOLOGY
............................................................11
STORAGE AND STABILITY
..........................................................................................12
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................12
PART II: SCIENTIFIC INFORMATION
...............................................................................14
PHARMACEUTICAL INFORMATION
..........................................................................14
CLINICAL TRIALS
..........................................................................................................14
DETAILED PHARMACOLOGY
...................................................
Preberite celoten dokument
